Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Exchange Rate Effect (2021 - 2025)

Historic Exchange Rate Effect for Strata Critical Medical (SRTAW) over the last 5 years, with Q3 2025 value amounting to -$616000.0.

  • Strata Critical Medical's Exchange Rate Effect fell 109354.84% to -$616000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$448000.0, marking a year-over-year decrease of 111818.18%. This contributed to the annual value of -$80000.0 for FY2024, which is 2121.21% down from last year.
  • As of Q3 2025, Strata Critical Medical's Exchange Rate Effect stood at -$616000.0, which was down 109354.84% from $151000.0 recorded in Q2 2025.
  • Strata Critical Medical's Exchange Rate Effect's 5-year high stood at $151000.0 during Q2 2025, with a 5-year trough of -$616000.0 in Q3 2025.
  • Moreover, its 5-year median value for Exchange Rate Effect was $3000.0 (2022), whereas its average is -$26866.7.
  • Examining YoY changes over the last 5 years, Strata Critical Medical's Exchange Rate Effect showed a top increase of 225714.29% in 2025 and a maximum decrease of 109354.84% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Exchange Rate Effect stood at -$9000.0 in 2021, then skyrocketed by 1000.0% to $81000.0 in 2022, then crashed by 81.48% to $15000.0 in 2023, then tumbled by 826.67% to -$109000.0 in 2024, then tumbled by 465.14% to -$616000.0 in 2025.
  • Its Exchange Rate Effect was -$616000.0 in Q3 2025, compared to $151000.0 in Q2 2025 and $126000.0 in Q1 2025.